Department of Exercise and Sports Science, University of North Carolina at Chapel Hill, CB#8700, 209 Fetzer Hall, Chapel Hill, NC, 27599, USA.
Department of Orthopaedics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Clin Rheumatol. 2023 Jul;42(7):1863-1874. doi: 10.1007/s10067-023-06568-x. Epub 2023 Mar 17.
INTRODUCTION/OBJECTIVE: To determine changes in gait biomechanics, quadricep strength, physical function, and daily steps after an extended-release corticosteroid knee injection at 4 and 8 weeks post-injection in individuals with knee osteoarthritis as well as between responders and non-responders based on changes in self-reported knee function.
The single-arm, clinical trial included three study visits (baseline, 4 weeks, and 8 weeks post-injection), where participants received an extended-release corticosteroid injection following the baseline visit. Time-normalized vertical ground reaction force (vGRF), knee flexion angle (KFA), knee abduction moment (KAM), and knee extension moment (KEM) waveforms throughout stance were collected during gait biomechanical assessments. Participants also completed quadricep strength, physical function (chair-stand, stair-climb, 20-m fast-paced walk) testing, and free-living daily step assessment for 7 days following each visit.
All participants demonstrated increased KFA excursion (i.e., greater knee extension angle at heel strike and KFA at toe-off), increased KEM during early stance, improved physical function (all p < 0.001), and increased quadricep strength at 4 and 8 weeks. KAM increased throughout most of stance at 4 and 8 weeks post-injection (p < 0.001) but appears to be driven by gait changes in non-responders. Non-responders demonstrated lesser vGRF during late stance and lesser KEM and KFA throughout stance compared to responders at baseline.
Extended-release corticosteroid injections demonstrated short-term improvements in gait biomechanics, quadricep strength, and physical function for up to 4 weeks. However, non-responders demonstrated gait biomechanics associated with osteoarthritis progression prior to the corticosteroid injection, suggesting that non-responders demonstrate more deleterious gait biomechanics prior to corticosteroid injection. Key Points • Individuals with knee osteoarthritis who were treated with extended-release corticosteroid injections demonstrated improvements in gait biomechanics and physical function for 8 weeks. • Individuals with knee osteoarthritis, who walked with aberrant walking biomechanics before treatment, failed to respond to extended-release corticosteroid treatment. • Future research should determine the mechanisms contributing to the short-term changes in gait biomechanics and physical function such as reduced inflammation.
简介/目的:确定膝关节骨关节炎患者在接受长效皮质类固醇膝关节注射后 4 周和 8 周时步态生物力学、股四头肌力量、身体功能和日常步数的变化,以及根据自我报告的膝关节功能变化,确定反应者和非反应者之间的变化。
这项单臂临床试验包括三次研究访问(基线、4 周和 8 周注射后),参与者在基线访问后接受长效皮质类固醇注射。在步态生物力学评估期间,收集整个站立阶段的时间归一化垂直地面反作用力(vGRF)、膝关节弯曲角度(KFA)、膝关节外展力矩(KAM)和膝关节伸展力矩(KEM)波形。参与者还在每次访问后 7 天内完成股四头肌力量、身体功能(坐立、爬楼梯、20 米快走)测试和自由生活日常步数评估。
所有参与者的 KFA 伸展度均增加(即足跟触地和足尖离地时的膝关节伸展角度更大),在早期站立时的 KEM 增加,身体功能改善(所有 p 值均<0.001),以及股四头肌力量在 4 周和 8 周时增加。在注射后 4 周和 8 周时,KAM 在整个站立阶段的大部分时间都增加(p 值均<0.001),但似乎是由非反应者的步态变化引起的。与反应者相比,非反应者在基线时在晚期站立时的 vGRF 较小,在整个站立阶段的 KEM 和 KFA 也较小。
长效皮质类固醇注射在长达 4 周的时间内显示出短期改善步态生物力学、股四头肌力量和身体功能。然而,非反应者在接受皮质类固醇注射前表现出与骨关节炎进展相关的步态生物力学,这表明非反应者在接受皮质类固醇注射前表现出更具破坏性的步态生物力学。关键点•接受长效皮质类固醇注射治疗的膝关节骨关节炎患者在 8 周内步态生物力学和身体功能得到改善。•在治疗前行走步态生物力学异常的膝关节骨关节炎患者对长效皮质类固醇治疗无反应。•未来的研究应确定导致步态生物力学和身体功能短期变化的机制,例如炎症减少。